We are accepting applications through the NC TraCS Pilot Award program to further innovative technologies to market.

Examples of the types of activities these pilot grants can fund:

  • Studies to validate the relevance of a biological target, e.g, through the use of small molecules or biologics to demonstrate a defined pharmaceutically relevant outcome
  • Validation of primary and secondary, functional assays, i.e., cells, tissues, animals in support of discovering a lead compound in an identified therapeutic area focus
  • Validation of a novel drug delivery system through use of known or novel compounds and biological materials, cells, vectors, polymers, animal models, or mechanical and electrical devices

FastTraCS Grants (R&D/Commercialization)

We are accepting applications through the NC TraCS Pilot Award program to further innovative technologies to market.

NEW!  Special Emphasis: NC State ASSIST & UNC Translational Research Collaborations

NC TraCS and the Center for Advanced Self-powered Systems of Integrated Sensors and Technologies (ASSIST) at NC State are seeking highly innovative proposals that address high-impact unmet clinical needs using NC State's ASSIST-developed technologies. The goal of this Special Emphasis is to match UNC providers' expertise of clinical challenges and unmet needs, with engineering faculty at ASSIST seeking to develop novel technology applications.

Watch the ASSIST-hosted Virtual Technology Showcase held on Monday May 3, 2021:

Technology examples include, but are not limited to:

  • Self-powered wearable biomonitoring devices (e.g., cardiac, respiratory, activity level)
  • Sensors integrated into textiles/apparel
  • Implantable diagnostics
  • Non-invasive biomarker monitoring (e.g., skin patch for sweat or interstitial fluid)
  • Gaseous/volatile sensor platforms

For additional information on ASSIST, visit assistcenter.org.

Any teams preparing to submit, either as part of existing collaborations or newly formed, may contact the following team members for information:

UNC | Andrew Kant (This email address is being protected from spambots. You need JavaScript enabled to view it.), Associate Director, FastTraCS
NC State | Adam Curry (This email address is being protected from spambots. You need JavaScript enabled to view it.), Innovation Ecosystem Director

View RFA

Examples of the types of activities these pilot grants can fund:

  • Studies to validate the relevance of a biological target, e.g, through the use of small molecules or biologics to demonstrate a defined pharmaceutically relevant outcome
  • Validation of primary and secondary, functional assays, i.e., cells, tissues, animals in support of discovering a lead compound in an identified therapeutic area focus
  • Validation of a novel drug delivery system through use of known or novel compounds and biological materials, cells, vectors, polymers, animal models, or mechanical and electrical devices
  • Studies designed to enhance animal and human toxicologic and drug safety in order to accelerate preclinical to Phase II development
  • Validation of novel pharmacogenomics approaches to forecast efficacy and/or safety of drugs in human populations
  • Validating a medical device prototype which may include optimization of device parameters, software-hardware integration and design and usability testing
  • Validation of in vitro diagnostic (IVD) or laboratory developed test (LDT) in human samples or populations

Investigators interested in applying for FastTraCS Pilot funding must answer pre-application questions by selecting the FastTraCS option in the request form dropdown menu, or contact This email address is being protected from spambots. You need JavaScript enabled to view it., FastTraCS Program Manager at least 30 days prior to the funding deadline.

Submission of a FastTraCS pre-application is mandatory to be considered eligible for FastTraCS Pilot funding. Investigators will be contacted within 5 business days of receipt of the pre-application.

View the FastTraCS RFA (pdf)

Submission Due Dates

June 29, 2021
November 2021

Note: Submissions should be received by 5:00 pm on the submission due dates.

Match Commitments

View a list of NC TraCS match commitments

New requirements for funded pilot grants

The NC TraCS Institute is funded through a CTSA grant from NIH's National Center for Advancing Translational Sciences (NCATS). NCATS recently instituted a new policy requiring the review and approval of all TraCS pilot grants involving human subjects research prior to TraCS funds being released. Therefore, if your proposal is funded and involves human subjects research, TraCS will require additional documentation to send to NCATS. NCATS expects to complete their review in less than 30 days.

NC TraCS Institute logo vertical

In partnership with:

Contact Us


Brinkhous-Bullitt, 2nd floor
160 N. Medical Drive
Chapel Hill, NC 27599

919.966.6022
This email address is being protected from spambots. You need JavaScript enabled to view it.

Social


Cite Us


CitE and SUBMit CTSA Grant number - UL1TR002489

© 2008-2021 The North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill
The content of this website is solely the responsibility of the University of North Carolina at Chapel Hill and does not necessarily represent the official views of the NIH   accessibility | contact